| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BEC | CTRPv2 | pan-cancer | AAC | -0.21 | 0.1 |
| mRNA | Vorinostat | FIMM | pan-cancer | AAC | -0.21 | 0.2 |
| mRNA | myriocin | CTRPv2 | pan-cancer | AAC | -0.2 | 0.2 |
| mRNA | Erlotinib | FIMM | pan-cancer | AAC | -0.2 | 0.3 |
| mRNA | Gefitinib | FIMM | pan-cancer | AAC | -0.19 | 0.2 |
| mRNA | fulvestrant | CTRPv2 | pan-cancer | AAC | -0.17 | 0.2 |
| mRNA | BRD-K78574327 | CTRPv2 | pan-cancer | AAC | -0.17 | 0.2 |
| mRNA | BRD-K75293299 | CTRPv2 | pan-cancer | AAC | -0.16 | 0.2 |
| mRNA | CEP-701 | FIMM | pan-cancer | AAC | -0.16 | 0.2 |
| mRNA | GDC-0941 | FIMM | pan-cancer | AAC | -0.14 | 0.5 |